Lab Automation Market worth $8.62 billion by 2031
The report "Lab Automation Market by Product (Robotic Arm, Microplate Reader, Workstation, Workcell, LIMS, ELN), Application (ADME, Drug Discovery, Diagnostic, Genomic, Proteomic, HTS), End User (Pharma, Forensic, Environmental, Diagnostic Lab)Global Forecast to 2031"is expected to grow from USD 6.60 billion in 2026 to USD 8.62 billion by 2031, representing a CAGR of 6.6%.
Browse 320 market data Tables and 60 Figures spread through 300 Pages and in-depth TOC on "Lab Automation Market by Product (Robotic Arm, Microplate Reader, Workstation, Workcell, LIMS, ELN), Application (ADME, Drug Discovery, Diagnostic, Genomic, Proteomic, HTS), End User (Pharma, Forensic, Environmental, Diagnostic Lab)Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/lab-automation-market-1158.html
The global lab automation market is projected to grow from USD 6.60 billion in 2026 to USD 8.62 billion by 2031, reflecting a CAGR of 6.6%. A significant factor driving this growth is the rising trend of high-throughput screening in drug discovery and diagnostics. Automation minimizes human error, enhancing reliability and precision, which makes it beneficial for both clinical applications and scientific research. Continuous advancements in robotics, artificial intelligence, and data analysis are further elevating lab automation technologies, improving their accuracy. Additionally, increasing investments by pharmaceutical companies in research and development are contributing to this trend.
Some of the key players in the lab automation market are Thermo Fisher Scientific (US), Tecan Group (Switzerland), Danaher Corporation (US), Agilent Technologies (US), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), Eppendorf AG (Germany), Becton, Dickinson and Company (US), Waters Corporation (US), Siemens Healthineers (Germany), Abbott Laboratories (US), bioMérieux (France), Hamilton Company (US), and Hudson Robotics (US).
The software segment is expected to register a significant growth rate over the forecast period.
The lab automation market is segmented by product type into automated workstations, off-the-shelf automated work cells, robotic systems, automated storage and retrieval systems, software, and other lab automation solutions. Among these, the software segment is anticipated to grow significantly during the forecast period. Laboratories require robust solutions for data integrity and traceability, which has led to the emergence of several important sub-segments within this software category. These include LIMS, ELNs, LES, and SDMS. The LIMS market is driven by the increasing need to manage large volumes of data efficiently. The demand for ELNs is further heightened by regulatory compliance requirements, intellectual property protection, and the effective management of laboratory instruments. Additionally, LES provides a paperless environment that enhances workflow productivity, contributing to market growth. Another key factor driving demand for SDMS is the growing need to collect and manage large volumes of data. As laboratories continuously seek ways to optimize their processes and boost productivity, the growth of these software solutions will remain a crucial element of the lab automation market.
The drug discovery segment accounted for the largest market share in 2025.
By application, the largest segment of lab automation is drug discovery, which involves highly complex, labor-intensive processes. Automation technologies help streamline compound testing and high-throughput screening stages. In addition to efficiently identifying potential drug candidates, these technologies reduce labor costs and shorten the time required to bring a drug to market. Companies like Agilent Technologies (US), PerkinElmer (US), Tecan Group (Switzerland), and Beckman Coulter (US) offer automation-specific solutions that can manage complete assay setups while minimizing the risk of human error. The rising demand for innovative therapeutics in oncology, neurology, and infectious diseases will continue to drive significant demand for automated solutions in the drug discovery segment of the lab automation market.
The hospitals & diagnostic laboratories segment accounted for the largest share in 2025.
The healthcare sector, particularly hospitals & diagnostic laboratories, requires high-throughput and efficient automation solutions. The rising prevalence of chronic diseases, emerging infectious disease outbreaks, and the need for rapid diagnostics have made it essential for laboratories to automate their processes. Automation helps reduce processing time, minimize human error, and enhance the accuracy of results. Key automation technologies include sample handling systems, liquid processing, and data management, enabling laboratories to conduct hundreds of tests without compromising quality. In conclusion, the ongoing automation of hospital and diagnostic laboratories is crucial in the lab automation market, as it boosts productivity and significantly improves turnaround times.
The US held the largest share of the North American market during the forecast period.
During the forecast period, the lab automation market in North America will be primarily led by the United States. This dominance is attributed to several key factors: the country boasts one of the most advanced healthcare infrastructures, hosts a number of prominent pharmaceutical and biotechnology companies, and is dedicated to investing in research and development to create innovative automated solutions. Additionally, the growth of this market will be driven by the increasing demand for efficient laboratory procedures, necessary to manage the rising volume of diagnostic tests and the development of new drugs. Healthcare innovations and the adoption of new technologies, supported by the US government, are further boosting demand for automated systems to enhance productivity and precision. Moreover, laboratories are quickly integrating new technologies, such as artificial intelligence and robotics, which solidifies the leading position of the US in the lab automation market across North America.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Lab Automation Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
